CRI Lifetree opened an early-stage research facility in Marlton, N.J. The site raises the company’s total bed count to 250 and adds capacity to conduct complex clinical trials.
The additional bed space and added capabilities for conducting complex neurology, pediatrics and normal healthy patient studies comes at a time of considerable need for the industry. Other facility features include six beds dedicated to first-in-human studies. This space has an observation area to allow clinicians and sponsors the access needed. The new center also has separate areas for elderly and pediatric populations. The 21,000-square-foot building adds to CRI Lifetree’s two other facilities in Philadelphia and Salt Lake City.
CRI Lifetree, formerly CRI Worldwide and Lifetree Clinical Research, is a leader in specialized, multitherapeutic inpatient and outpatient early-stage research.
Date: July 10, 2012
Source: CRI Lifetree
Filed Under: Drug Discovery
